Range
24.28 - 26.55
Vol / Avg.
131.4K/85.3K
Div / Yield
-
52 Wk
12.82 - 37.51
Mkt Cap
948.5M
Payout Ratio
-
Open
26.55
P/E
-
EPS
-0.74
Shares
38.2M
Outstanding
38.2M
Total Float
14.7M
Benzinga - May 10, 2021, 4:14PM
load more
Aligos Therapeutics Inc is a clinical-stage biopharmaceutical company. It is engaged in developing novel therapeutics to address unmet medical needs in viral and liver diseases, including chronic hepatitis B and coronaviruses, and therapeutics for nonalcoholic steatohepatitis (NASH). The company's pipeline includes ALG-010133, ALG-000184, ALG-020572 and ALG-055009, among others.

Earnings

see more
Q1 2021Est.ActualSurprise
EPS-0.900-0.740 0.1600
REV910.000K
Q4 2020Est.ActualSurprise
EPS-1.090
REV0

Analyst Ratings

see more
DateAnalyst FirmAnalyst NameActionRatingAction Price Prior Price Target

Related Companies

TickerCompanyChg %Mkt Cap
ALGSAligos Therapeutics-7.72%948.5M

Aligos Therapeutics Frequently Asked Questions

Q

How do I buy Aligos Therapeutics (ALGS) stock?

A

You can purchase shares of Aligos Therapeutics (NASDAQ: ALGS) through any online brokerage.

View our list of the best stock brokerages.

Q

Who are Aligos Therapeutics's (ALGS) competitors?

A

There are no as such competitors for Aligos Therapeutics.

Q

What is the target price for Aligos Therapeutics (ALGS) stock?

A

The latest price target for Aligos Therapeutics (NASDAQ: ALGS) was reported by Jefferies on November 10, 2020. The analyst firm set a price target for 26.00 expecting ALGS to rise to within 12 months (a possible 4.59% upside). 3 analyst firms have reported ratings in the last year.

Q

Current Stock Price for Aligos Therapeutics (ALGS)?

A

The stock price for Aligos Therapeutics (NASDAQ: ALGS) is $24.86 last updated Tue Jun 22 2021 20:00:03 GMT+0000 (Coordinated Universal Time).

Q

Does Aligos Therapeutics (ALGS) pay a dividend?

A

There are no upcoming dividends for Aligos Therapeutics.

Q

When is Aligos Therapeutics (NASDAQ:ALGS) reporting earnings?

A
Aligos Therapeutics’s Q2 earnings are confirmed for after-market on August 2, 2021.
Q

Is Aligos Therapeutics (ALGS) going to split?

A

There is no upcoming split for Aligos Therapeutics.

Q

What sector and industry does Aligos Therapeutics (ALGS) operate in?

A

Aligos Therapeutics is in the Consumer Discretionary sector and Multiline Retail industry. They are listed on the NASDAQ.